Comments
Dr Reddy’s Laboratories Ltd has launched Doxercalciferol injection in the US market. It is the therapeutic generic equivalent of Hectorol (doxercalciferol) injection approved by the US Food and Drug Administration (USFDA).
The Hectorol Single-Dose Vials and Multiple-Dose Vials brand and generics had US sales of approximately $138 million for the most recent twelve months ending in September 2019 according to IQVIA Health.. Hectorol is a trademark of Sanofi-Aventis US LLC, according to a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.